Abingworth Bioventures III and IV invested in bone and joint medication company Galápagos and women’s health company Gynesonics, respectively.
2 min read · 13 November 2014
The TTP Ventures portfolio includes electronic shelf labels company Displaydata and drug development company Pulmagen Therapeutics.
1 min read · 10 November 2014
The portfolio consists of two to three fund of funds managed by Silicon Valley Bank.
1 min read · 06 November 2014
Akkadian Ventures III will invest in direct secondaries deals focused on media, technology and telecommunications.
1 min read · 29 October 2014
The Israeli fund of funds manager will buy low-funded secondaries and early secondaries positions in venture capital funds and in technology-related private equity funds.
2 min read · 16 October 2014
Private equity and venture capital firms continue to see London as a key European hub, according to a report by financial data company Qodeo.
2 min read · 05 October 2014
Venture capital specialist Industry Ventures has closed its third fund of funds above its $125m target.
1 min read · 30 September 2014
The venture capital specialist has collected $202m toward the fund’s $404m target.
2 min read · 21 September 2014
An increasing number of private equity secondaries transactions focused on small buyout and venture capital managers has helped Adveq find value in the market, explains Nico Taverna, head of the firm’s secondaries programme.
4 min read · 21 September 2014
The Paul Capital spin-out is in market with its first dedicated venture capital secondaries and co-investment fund.
1 min read · 11 September 2014
